Filing Flows › Traws Pharma (TRAW) › Q2 2025 › vs Q1 2025
Traws Pharma (TRAW) Q2 2025 vs Q1 2025 (quarter over quarter)
Traws Pharma's revenue rose $2.7M (48×) from $57K in Q1 2025 to $2.7M in Q2 2025.
Traws Pharma, Q2 2025: revenue $2.7M (48× year over year), operating margin -45.7%, net loss $915K, operating cash flow −$6.0M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q2 2025 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $2.7M | $57K | $2.7M | 48× |
| Other income, net | $334K | $26.7M | −$26.4M | -99% |
| Net loss | $915K | −$21.5M | $22.4M | — |
| Costs & expenses | $4.0M | $26.8M | −$22.8M | -85% |
| Operating costs | $4.0M | $5.3M | −$1.3M | -24% |
| Research & development | $2.3M | $2.5M | −$215K | -9% |
| General & admin | $1.7M | $2.8M | −$1.1M | -39% |
| Operating cash sources | $6.1M | $5.6M | $486K | +9% |
| Depreciation & amortization | $1K | $1K | $0 | 0% |
| Share-based compensation | $105K | $161K | −$56K | -35% |
| Cash used in operations | $6.0M | $5.4M | $542K | +10% |
| Net loss absorbed | $915K | −$21.5M | $22.4M | — |
| Working capital & other | $5.2M | $27.1M | −$21.9M | -81% |
Questions
How much did Traws Pharma's revenue grow quarter over quarter in Q2 2025?
Traws Pharma's revenue rose $2.7M (48×) from $57K in Q1 2025 to $2.7M in Q2 2025.